Top Markets
#1 Siren Siren +34.84%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.77%
#3 Ribbita by Virtuals Ribbita by Virtuals +20.39%
#4 Wiki Cat Wiki Cat +20.32%
#5 Cysic Cysic +17.69%
#6 PulseChain PulseChain +16.52%
#7 Velvet Velvet +16.46%
#8 The Grays Currency The Grays Currency +16.46%
#9 KUB Coin KUB Coin +16.41%
#10 BasedHype BasedHype +14.69%
Coin of the day
Siren Siren
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Classifica tra le azioni #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Prezzo delle azioni
$0.404
Capitalizzazione di mercato
$14.28M
Variazione (1 giorno)
-10.42%
Variazione (1 anno)
-67.68%
Paese
IL
Scambia NeuroSense Therapeutics Ltd. (NRSN)

Categoria

Healthcare
Rapporto P/B per NeuroSense Therapeutics Ltd. (NRSN)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di NeuroSense Therapeutics Ltd., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per NeuroSense Therapeutics Ltd. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE